Low-dose naproxen increases frequency of adverse health effects and does not reduce progression of presymptomatic Alzheimer disease in cognitively intact persons at risk.
Low scam awareness is associated with an increased risk for Alzheimer disease and mild cognitive impairment among older adults.
Use of the orally administered β-site amyloid precursor protein-cleaving enzyme 1 inhibitors, verubecestat and atabecestat, does not prevent clinical progression to Alzheimer disease.
Having a shorter reproductive span is associated with an increased risk for dementia in women.
Gerontologists, practicing ethicists, policymakers, and health practitioners should consider the structural conditions of long-term care that both foster aggression and constrain prevention efforts, according to this commentary.
After adjusting for the competing risk of death without dementia, smoking is not associated with an increased risk for dementia.
Patients with poor cognitive function have significantly lower levels of Alzheimer disease-related biomarkers in the vitreous humor.
Researchers sought to identify variables that were associated with suicidal ideation or behavior in patients with Huntington disease.
Memantine monotherapy was associated with a 7% lower risk for any cardiovascular event compared with both acetylcholinesterase inhibitor monotherapy and combination therapy, according to a new study.
The development of levodopa-induced dyskinesia (LID) appears to correlate with cognitive decline, as well as with the development of Parkinson disease (PD) dementia, researchers found. The findings from this study were published in Neurology. A total of 119 patients with PD who were treated with levodopa for more than 5 years were included in this…